Integrated Filing — IndAS


General information about company

Scrip Code 500085
NSE Symbol CHAMBLFERT
MSEI Symbol NOTLISTED
ISIN INE085A01013
Name of company CHAMBAL FERTILIZERS & CHEMICALS LIMITED
Type of company Main Board
Class of security Equity
Date of start of financial year 01-Apr-2024
Date of end of financial year 31-Mar-2025
Date of board meeting when results were approved 08-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 25-Apr-2025
Description of presentation currency INR (in Actuals)
Reporting Type Quarterly
Reporting Quarter Fourth quarter
Nature of report standalone or consolidated Consolidated
Whether results are audited or unaudited for the quarter ended Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Multi segment
Description of single segment
Start date and time of board meeting 08-May-2025   14:31:00
End date and time of board meeting 08-May-2025   16:03:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion



Financial Results Ind-AS

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Consolidated Consolidated
Part I Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1 Income
Revenue from operations 24487300000 166462000000
Other income 552700000 2151100000
Total income 25040000000 168613100000
2 Expenses
(a) Cost of materials consumed 12918700000 64346500000
(b) Purchases of stock-in-trade 10079300000 34262800000
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade -11039200000 -5448300000
(d) Employee benefit expense 615900000 2332400000
(e) Finance costs 0 484200000
(f) Depreciation, depletion and amortisation expense 816200000 3301500000
(f) Other Expenses
1 Other Expenses 10279000000 46133900000
Total other expenses 10279000000 46133900000
Total expenses 23669900000 145413000000
3 Total profit before exceptional items and tax 1370100000 23200100000
4 Exceptional items 0 0
5 Total profit before tax 1370100000 23200100000
6 Tax expense
7 Current tax 407300000 4545900000
8 Deferred tax -33200000 3477300000
9 Total tax expenses 374100000 8023200000
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0 0
11 Net Profit Loss for the period from continuing operations 996000000 15176900000
12 Profit (loss) from discontinued operations before tax 0 0
13 Tax expense of discontinued operations 0 0
14 Net profit (loss) from discontinued operation after tax 0 0
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 307100000 1317000000
16 Total profit (loss) for period 1303100000 16493900000
17 Other comprehensive income net of taxes 600500000 1250600000
18 Total Comprehensive Income for the period 1903600000 17744500000
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent 1303600000 16495100000
Total profit or loss, attributable to non-controlling interests -500000 -500000
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent 1903800000 17749900000
Total comprehensive income for the period attributable to owners of parent non-controlling interests -200000 -5400000
21 Details of equity share capital
Paid-up equity share capital 4006500000 4006500000
Face value of equity share capital 10 10
27 Details of debt securities
22 Reserves excluding revaluation reserve 83273700000
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 3.25 41.17
Diluted earnings (loss) per share from continuing operations 3.25 41.17
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 3.25 41.17
Diluted earnings (loss) per share from continuing and discontinued operations 3.25 41.17
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results Kindly refer attached pdf for notes and clarifications n



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-Apr-2024
Date of end of reporting period 31-Mar-2025
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Consolidated
Assets
1 Non-current assets
Property, plant and equipment 62180700000
Capital work-in-progress 6493500000
Investment property 0
Goodwill 0
Other intangible assets 31200000
Intangible assets under development 3700000
Biological assets other than bearer plants 0
Investments accounted for using equity method 5439500000
Non-current financial assets
Non-current investments 200000
Trade receivables, non-current 0
Loans, non-current 400000
Other non-current financial assets 39600000
Total non-current financial assets 40200000
Deferred tax assets (net) 0
Other non-current assets 3657700000
Total non-current assets 77846500000
2 Current assets
Inventories 18022900000
Current financial asset
Current investments 8282400000
Trade receivables, current 3679200000
Cash and cash equivalents 1077500000
Bank balance other than cash and cash equivalents 1285700000
Loans, current 200000
Other current financial assets 1610100000
Total current financial assets 15935100000
Current tax assets (net) 0
Other current assets 2257400000
Total current assets 36215400000
3 Non-current assets classified as held for sale 5200000
4 Regulatory deferral account debit balances and related deferred tax Assets 0
Total assets 114067100000
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 4006500000
Other equity 83273700000
Total equity attributable to owners of parent 87280200000
Non controlling interest -160300000
Total equity 87119900000
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 823300000
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises 0
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 0
Total Trade payable 0
Other non-current financial liabilities 138700000
Total non-current financial liabilities 962000000
Provisions, non-current 84000000
Deferred tax liabilities (net) 14117700000
Deferred government grants, Non-current 0
Other non-current liabilities 42200000
Total non-current liabilities 15205900000
Current liabilities
Current financial liabilities
Borrowings, current 0
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 311200000
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 5991500000
Total Trade payable 6302700000
Other current financial liabilities 4181100000
Total current financial liabilities 10483800000
Other current liabilities 854500000
Provisions, current 403000000
Current tax liabilities (Net) 0
Deferred government grants, Current 0
Total current liabilities 11741300000
3 Liabilities directly associated with assets in disposal group classified as held for sale 0
4 Regulatory deferral account credit balances and related deferred tax liability 0
Total liabilities 26947200000
Total equity and liabilites 114067100000
Disclosure of notes on assets and liabilities Textual Information(1)



Text Block

Textual Information(1) Kindly refer attached pdf for notes and clarifications



Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-Jan-2025 01-Apr-2024
Date of end of reporting period 31-Mar-2025 31-Mar-2025
Whether accounts are audited or unaudited Audited Audited
Nature of report standalone or consolidated Consolidated Consolidated
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
1 Own Manufactured Fertilisers 22431400000 131586800000
2 Complex Fertilisers 1668200000 25614100000
3 Crop Protection Chemicals and Speciality Nutrients 387700000 9261100000
4 Others 0 0
Total Segment Revenue 24487300000 166462000000
Less: Inter segment revenue 0 0
Revenue from operations 24487300000 166462000000
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
1 Own Manufactured Fertilisers 789900000 18360000000
2 Complex Fertilisers 93400000 1737100000
3 Crop Protection Chemicals and Speciality Nutrients 61900000 2136300000
4 Others -900000 -1100000
Total Profit before tax 944300000 22232300000
i. Finance cost 0 0
ii. Other Unallocable Expenditure net off Unallocable income -732900000 -732900000
Profit before tax 1677200000 24517100000
3 (Segment Asset - Segment Liabilities)
Segment Asset
1 Own Manufactured Fertilisers 72577800000 72577800000
2 Complex Fertilisers 16012900000 16012900000
3 Crop Protection Chemicals and Speciality Nutrients 1704700000 1704700000
4 Others 7231500000 7231500000
Total Segment Asset 97526900000 97526900000
Un-allocable Assets 16540200000 16540200000
Net Segment Asset 114067100000 114067100000
4 Segment Liabilities
Segment Liabilities
1 Own Manufactured Fertilisers 8636700000 8636700000
2 Complex Fertilisers 1464500000 1464500000
3 Crop Protection Chemicals and Speciality Nutrients 864700000 864700000
4 Others 1355600000 1355600000
Total Segment Liabilities 12321500000 12321500000
Un-allocable Liabilities 14625700000 14625700000
Net Segment Liabilities 26947200000 26947200000
Disclosure of notes on segments Textual Information(2)



Text Block

Textual Information(2) Kindly refer attached pdf for notes and clarifications



Other Comprehensive Income

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Consolidated Consolidated
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Re-measurement Gain / (Loss) on Defined Benefit Plans 29100000 5800000
Total Amount of items that will not be reclassified to profit and loss 29100000 5800000
2 Income tax relating to items that will not be reclassified to profit or loss 16100000 8400000
3 Amount of items that will be reclassified to profit and loss
1 Exchange Difference Gain on Translation of Foreign Operations 564400000 502300000
2 Effective Portion of Exchange Difference (Loss) on Hedging Instruments 0 -16500000
3 Effective Portion of Exchange Difference Loss on Hedging Instruments re-classified n to Profit or Loss 367900000 1469800000
Total Amount of items that will be reclassified to profit and loss 932300000 1955600000
4 Income tax relating to items that will be reclassified to profit or loss 344800000 702400000
5 Total Other comprehensive income 600500000 1250600000



Cash flow statement, indirect

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 2024-04-01
B Date of end of reporting period 2025-03-31
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Consolidated
Part I Blue color marked fields are non-mandatory.
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 23200100000
Adjustments for reconcile profit (loss)
Adjustments for finance costs 336900000
Adjustments for decrease (increase) in inventories -5570200000
Adjustments for decrease (increase) in trade receivables, current -1768100000
Adjustments for decrease (increase) in trade receivables, non-current 0
Adjustments for decrease (increase) in other current assets 2402300000
Adjustments for decrease (increase) in other non-current assets -1926600000
Adjustments for other financial assets, non-current 2200000
Adjustments for other financial assets, current -481800000
Adjustments for other bank balances 0
Adjustments for increase (decrease) in trade payables, current -1630400000
Adjustments for increase (decrease) in trade payables, non-current 0
Adjustments for increase (decrease) in other current liabilities 51700000
Adjustments for increase (decrease) in other non-current liabilities 500000
Adjustments for depreciation and amortisation expense 3301500000
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss -48300000
Adjustments for provisions, current -16100000
Adjustments for provisions, non-current -157500000
Adjustments for other financial liabilities, current -74300000
Adjustments for other financial liabilities, non-current 23900000
Adjustments for unrealised foreign exchange losses gains -10800000
Adjustments for dividend income 0
Adjustments for interest income 210300000
Adjustments for share-based payments 0
Adjustments for fair value losses (gains) 0
Adjustments for undistributed profits of associates 0
Other adjustments for which cash effects are investing or financing cash flow 245800000
Other adjustments to reconcile profit (loss) 0
Other adjustments for non-cash items 150500000
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0
Total adjustments for reconcile profit (loss) -5379100000
Net cash flows from (used in) operations 17821000000
Dividends received 0
Interest paid 0
Interest received 0
Income taxes paid (refund) 3882000000
Other inflows (outflows) of cash 0
Net cash flows from (used in) operating activities 13939000000
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0
Cash flows used in obtaining control of subsidiaries or other businesses 0
Other cash receipts from sales of equity or debt instruments of other entities 0
Other cash payments to acquire equity or debt instruments of other entities 0
Other cash receipts from sales of interests in joint ventures 0
Other cash payments to acquire interests in joint ventures 0
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0
Proceeds from sales of property, plant and equipment 27500000
Purchase of property, plant and equipment 5718400000
Proceeds from sales of investment property 0
Purchase of investment property 0
Proceeds from sales of intangible assets 0
Purchase of intangible assets 11100000
Proceeds from sales of intangible assets under development 0
Purchase of intangible assets under development 500000
Proceeds from sales of goodwill 0
Purchase of goodwill 0
Proceeds from biological assets other than bearer plants 0
Purchase of biological assets other than bearer plants 0
Proceeds from government grants 0
Proceeds from sales of other long-term assets 0
Purchase of other long-term assets 0
Cash advances and loans made to other parties 0
Cash receipts from repayment of advances and loans made to other parties 0
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0
Dividends received 1389000000
Interest received 207200000
Income taxes paid (refund) 0
Other inflows (outflows) of cash 11497000000
Net cash flows from (used in) investing activities 7390700000
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0
Payments from changes in ownership interests in subsidiaries 0
Proceeds from issuing shares 0
Proceeds from issuing other equity instruments 0
Payments to acquire or redeem entity's shares 0
Payments of other equity instruments 0
Proceeds from exercise of stock options 0
Proceeds from issuing debentures notes bonds etc 0
Proceeds from borrowings 0
Repayments of borrowings 17835500000
Payments of lease liabilities 56500000
Dividends paid 3205200000
Interest paid 255400000
Income taxes paid (refund) 0
Other inflows (outflows) of cash 0
Net cash flows from (used in) financing activities -21352600000
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes -22900000
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 1800000
Net increase (decrease) in cash and cash equivalents -21100000
Cash and cash equivalents cash flow statement at beginning of period 1098600000
Cash and cash equivalents cash flow statement at end of period 1077500000







Details of Impact of Audit Qualification

Whether results are audited or unaudited Audited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 Price Waterhouse Chartered Accountants LLP Yes 30-Nov-2026


Financial details

Sr. Particulars Audited Figures (as reported before adjusting for qualifications) Adjusted Figures (audited figures after adjusting for qualifications)
1 Turnover / Total income
2 Total Expenditure
3 Net Profit/(Loss)
4 Earnings Per Share
5 Total Assets
6 Total Liabilities
7 Net Worth




Signatories detail

Name of CEO / Managing director
Name of CFO
Name of audit committee chairman
Name of statutory auditor
Name of other signatory, if any, with designation
Place
Date